GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » Shiller PE Ratio

VIVUS (STU:VIU1) Shiller PE Ratio : (As of May. 15, 2024)


View and export this data going back to . Start your Free Trial

What is VIVUS Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


VIVUS Shiller PE Ratio Historical Data

The historical data trend for VIVUS's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS Shiller PE Ratio Chart

VIVUS Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

VIVUS Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of VIVUS's Shiller PE Ratio

For the Biotechnology subindustry, VIVUS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VIVUS's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIVUS's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where VIVUS's Shiller PE Ratio falls into.



VIVUS Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

VIVUS's E10 for the quarter that ended in Mar. 2020 is calculated as:

For example, VIVUS's adjusted earnings per share data for the three months ended in Mar. 2020 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2020 (Change)*Current CPI (Mar. 2020)
=-0.443/108.9015*108.9015
=-0.443

Current CPI (Mar. 2020) = 108.9015.

VIVUS Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201006 -2.290 91.962 -2.712
201009 -1.679 92.162 -1.984
201012 -0.605 92.474 -0.712
201103 -0.859 94.283 -0.992
201106 -1.388 95.235 -1.587
201109 -0.739 95.727 -0.841
201112 -0.988 95.213 -1.130
201203 -1.541 96.783 -1.734
201206 -1.921 96.819 -2.161
201209 -3.121 97.633 -3.481
201212 -4.291 96.871 -4.824
201303 -4.109 98.209 -4.556
201306 -4.177 98.518 -4.617
201309 -3.590 98.790 -3.957
201312 -1.241 98.326 -1.374
201403 -1.084 99.695 -1.184
201406 -1.840 100.560 -1.993
201409 -1.164 100.428 -1.262
201412 -2.027 99.070 -2.228
201503 -1.386 99.621 -1.515
201506 -4.277 100.684 -4.626
201509 -1.336 100.392 -1.449
201512 -1.102 99.792 -1.203
201603 -1.078 100.470 -1.168
201606 -0.979 101.688 -1.048
201609 -0.802 101.861 -0.857
201612 5.119 101.863 5.473
201703 -0.093 102.862 -0.098
201706 -1.157 103.349 -1.219
201709 -0.478 104.136 -0.500
201712 -0.845 104.011 -0.885
201803 -0.811 105.290 -0.839
201806 -1.010 106.317 -1.035
201809 -0.746 106.507 -0.763
201812 -0.369 105.998 -0.379
201903 -0.664 107.251 -0.674
201906 -0.496 108.070 -0.500
201909 -0.944 108.329 -0.949
201912 -0.549 108.420 -0.551
202003 -0.443 108.902 -0.443

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


VIVUS  (STU:VIU1) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


VIVUS Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of VIVUS's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


VIVUS (STU:VIU1) Business Description

Traded in Other Exchanges
N/A
Address
900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008
VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines